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Abstract Individuals with bicuspid aortic valve (BAV) are at
significantly higher risk of developing serious aortic complica-
tions than individuals with tricuspid aortic valves (TAV). Stud-
ies have indicated an altered aortic blood flow in patients with
BAV; however, the extent to which altered flow influences the
pathological state of BAVaorta is unclear. In the present study,
we dissected flow-mediated aortic gene expression in patients
undergoing elective open heart surgery. A large collection of
public microarray data sets were firstly screened for consistent
co-expression with five well-characterized flow-regulated
genes (query genes). Genes with co-expression probability of
>0.5 were selected and further analysed in expression profiles
(127 arrays) from ascending aorta of BAV and TAV patients.
Forty-four genes satisfied two filtering criteria: a significant
correlation with one or more of the query genes (R>0.40) and
differential expression between patients with BAVand TAV. No
gene fulfilled the criteria in mammary artery (88 arrays), an
artery not in direct contact with the valve. Fifty-five percent of
the genes significantly altered between BAVand TAV patients
showed differential expression between two identified flow
regions in the rat aorta. A large proportion of the identified
genes were related to angiogenesis and/or wound healing, with
pro-angiogenesis genes downregulated and inhibitory genes
upregulated in patients with BAV. Moreover, differential ex-
pression of ZFP36, GRP116 and PKD2 was confirmed using
immunohistochemistry. Implementing a new strategy, we have
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demonstrated an angiostatic gene expression signature in
patients with BAV, indicating impaired wound healing in these
patients, potentially involved in BAV-associated aortopathy.
Keywords Aortic aneurysm . Transcriptome .Wound
healing . Aorta . Thoracic . Congenital heart defects
Introduction
Bicuspid aortic valve (BAV) is a common congenital disor-
der with a prevalence of 1–2 % in the population. BAV
patients are at higher risk of aneurysm and/or dissection
than patients with a tricuspid aortic valve (TAV), even after
aortic valve replacement [1].
Two major hypotheses have been put forth to describe the
pathogenesis and sensitivity of the proximal aorta to dilation
in BAV patients. The ‘genetic theory’ postulates a genetic/
developmental component causing aortic fragility, while the
‘hemodynamic theory’ proposes influence of an abnormal
blood flow as a causal factor [2]. Indeed, a collective set of
data has demonstrated an abnormal blood flow in the as-
cending aorta of patients with BAV, with increased flow
velocities directed towards the convexity of aortic arch
[3, 4]. This particular site coincides with the asymmetrical
location of pathological changes in the BAV media [2],
suggesting an involvement of flow in the pathology behind
BAV aortopathy.
Wall shear stress (WSS) is the frictional force acting on
the endothelium as a consequence of blood flow and a key
determinant of vascular morphogenesis and vessel physiol-
ogy in adult life. Exposure of endothelial cells (ECs) to
WSS triggers a diverse set of responses, the nature of which
encompasses many aspects of cellular metabolism, such as
modulation of ion channels, cellular reorganization and
changes in cell shape, as well as activation of a set of
transcription factors with concomitant activation of their
targets [5].
A great deal of research has been carried out mea-
suring gene expression in different types of ECs and
vascular smooth muscle cells (VSMCs) exposed to flow
in vitro (reviewed in [6]), or by exposing vessels to
abnormal blood flow in experimentally manipulated an-
imal models [7, 8]. This has resulted in characterization
of a set of shear-responsive genes and identification of
Krüppel-like factor 2 (KLF2) as one of the key players
in transducing changes in blood flow into EC-specific
flow-induced gene expression [6]. KLF2, which has a
substantial functional overlap with Krüppel-like factor 4
(KLF4) [9], conveys shear stress signals to the regula-
tion of endothelial homeostasis, establishment of an
anti-inflammatory phenotype and induction of vasopro-
tective genes. Moreover, although the effect of shear
stress is primarily sensed by ECs, this effect is further
transduced to and sensed by other cell layers in the
vessel walls (reviewed in [10]). One example is KLF2
where an EC-specific mutation of KLF2 changes the
vascular tone in embryos [11].
The purpose of the present study was to investigate
whether or not the abnormal blood flow associated with
BAV morphology could possibly give rise to a flow-
mediated type of gene expression signature specifically
associated with BAV phenotype. To study the potential
regulatory signals exerted by shear stress on ECs, and
in the natural contexts of its interaction with the
VSMCs, we used biopsies containing intima–media of
the vessel walls of BAV and TAV patients. We firstly
used the method ‘expression screening’, which is based
on the reasoning that genes showing consistent correla-
tion of mRNA levels across different experimental
conditions and in different tissues are likely to be func-
tionally related, in order to identify novel flow-mediated
genes. A large collection of public microarray data sets
is screened for genes consistently co-expressed with a
set of selected well-characterized flow-regulated genes,
so-called query genes (step 1, Fig. 1). Genes selected by
this procedure were then analysed for co-expression
with the query genes in an expression database consist-
ing of array data from intima–media of ascending aorta
of BAV and TAV patients (step 2), and the genes that
were highly correlated to one or more queries were
analysed for association with valve morphology (step
3). To verify that the identified genes are influenced
by flow, the mRNA expressions were investigated in
regions of rat aortic arch, characterized as being ex-
posed to a disturbed and uniform flow pattern, respec-
tively (step 4). Finally, the protein expression of some
genes was evaluated by immunohistochemistry. The
study identified novel flow-mediated genes associated
with BAV.
Materials and methods
Detailed experimental protocols are described in the
“Supplemental materials”.
Human material—the ASAP study
The collection of biopsy samples from the Advanced
Study of Aortic Pathology (ASAP) database has been
described in detail previously [12]. Briefly, biopsies
were taken from the anterior side of the ascending
aorta, a few centimeters above the valve and from the
mammary artery of patients undergoing aortic valve
surgery which were having either a BAV or a TAV
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and dilated or non-dilated ascending aorta. Patients with
atherosclerosis (lacking significant stenosis on coronary
angiogram) were excluded from the study, and no
patients with dissection were included. Demographic
data have been presented in detail previously [13]. The
study was approved by the regional Human Research
Ethics Committee. Oral and written consent was
obtained from all patients according to the Declaration
of Helsinki.
Expression screening
The expression screening algorithm has been previously
described [14, 15]. Briefly, we used this algorithm to search
a repository of 1,512 mouse, rat and human Affymetrix
microarray data sets for "informative" data sets where the
query genes are co-expressed. Next, a weighted meta-
analysis was performed to discover additional genes corre-
lating with the query genes, where the most "informative"
data sets are given largest weights. The outcome of this
analysis is a Bayesian posterior probability, which reflects
the accumulated evidence for co-expression after consider-
ing all data sets. We selected genes with a posterior proba-
bility greater than 0.5.
Determination of flow regions in rat
Animal-specific WSS magnitude and vector direction were
estimated in the aortic arch of nine male Wistar rats using
computational fluid dynamic based on aortic geometry and
flow information acquired by magnetic resonance imaging.
Isolation of RNA
A second set of totally 70 rats was used for analysis of flow-
dependent gene expression. In brief, two regions within the
same aorta, exposed to a disturbed and uniform flow pattern,
respectively, were cut out, and total RNAwas isolated using
RNeasy Mini Kit.
Gene arrays
Affymetrix GeneChip Human Exon 1.0 STarrays, Affymetrix
Rat 1.1 ST Titan arrays and protocols were used. Details for
transcriptional profiling in the ASAP study have been de-
scribed previously [12]. Transcriptional profiling of rat aorta
was performed on 28 samples (14 pairs of disturbed and
uniform flow pattern samples). Microarray results from aortic
intima–media were validated by qRT-PCR on 171 samples
(127 overlap with microarray cohort) for 11 genes [12].
Quantitative real-time polymerase chain reaction
Each sample was analysed in triplicates, and standard curve
methodology was used for quantification of specific gene
targets.
Immunohistochemistry
Immunostaining was performed on non-dilated aortic sec-
tion from BAV and TAV patients (n06 BAV and 6 TAV).
Deparaffinised tissue sections (5 μm of thickness) were
treated with DIVA solution.
Statistical analysis
When P values are reported (Supplementary Table 2), they
are from the association between gene expression and cus-
pidity, with dilation status, stenosis and regurgitation as
covariates. Differential expression of rat RNA microarray
data was investigated using a paired Student’s t test assum-
ing unequal variance. Correction for multiple testing of gene
expression between clinical phenotypes, and between flow
regions in rat was done using Benjamini–Hochberg False
Discovery Rate correction (FDR) as implemented in the
multtest R package. Comparisons between expression of
different genes were performed using a Pearson product–
moment correlation, with a cutoff of R>0.40.
Fig. 1 Schematic illustration of data analysis workflow
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Results
Identifying flow-associated gene expression
Five ‘query genes’ were selected based on thorough evalua-
tion of published data regarding shear-sensitive genes. Special
effort was made in order to select well-characterized and well-
established shear-sensitive genes, all of which had to be
expressed in the vessel wall. KLF2 and KLF4, the main
transcription factors specifically induced in response to shear
stress in ECs [5]; PKD2, a component of cilia and sensor of
shear stress causing autosomal dominant polycystic kidney
disease with accompanying cardiovascular phenotypes [16];
thrombomodulin (THBD), a shear stress-induced anti-
coagulant associated with aortic remodelling [17]; and tyro-
sine kinase receptor 1, which is almost exclusively EC-
specific and induced in a flow-dependent manner in experi-
mentally manipulated animal vessels [18]. We next used a
computational method termed ‘expression screening’ [14, 15]
to search a repository of 1,512 mouse, rat and human micro-
array data sets for where the query genes are co-expressed,
and determined which other genes were consistently co-
expressed with the query genes in those data sets. Of note,
in these data sets, co-expression with query genes is not only
in the context of shear stress or mechanosensory activities but
also in a wide range of other cellular functions (inevitably, all
the queries have several other functions apart from being shear
stress responsive). This identified 122 genes with a co-
expression probability of >0.5 (Step 1, Fig. 1), presented in
Supplementary Table 1a. To check the robustness of the query
genes selection, we repeated the procedure with four addition-
al flow-induced genes as queries, namely nitric oxide synthase
3, heme oxygenase 1, SHC-transforming protein 1 and sirtuin
1. This resulted in the selection of 117 genes, all of whichwere
included in the previous list (Supplementary Table 1b).
Flow-associated gene expression in patients with BAV
We then analysed co-expression of the 122 genes identified
by expression screening with the initial 5 query genes in the
ASAP microarray data set [12, 13] containing expression
profiles from ascending thoracic aorta (127 arrays from
intima/media, 81 BAV and 46 TAV; Step 2, Fig. 1). As
expected, a large proportion of the genes from step 1
showed co-expression with one or more of the five query
genes in the ascending aorta (n072, Supplementary
Table 2a). A Pearson correlation coefficient of 0.40
was used as cutoff for further analyses (FDR of 5 %,
P<0.0137 corresponds to R00.143; Bonferroni correction,
P<6.01e−05 corresponds to R00.404).
In a third step, differential expression between BAV and
TAV patients was evaluated using multivariate analysis. To
take the effect of other disease phenotypes into consideration,
aortic dilatation, regurgitation and stenosis were included as
covariates. A cutoff of FDR 5 % (P<0.0140) was used to
determine association. Of the 72 genes showing correlation
with at least one of the 5 query genes, 44 genes were differ-
entially expressed in the ascending aorta between BAV and
TAV patients (Table 1 and Supplementary Table 2a). The
putative functions of these genes are listed in Table 1 (includ-
ing references in Supplementary Table 3). A large proportion
of the identified genes were related to angiogenesis and/or
wound healing. Further search in PubMed revealed that 89 %
(39 out of 44) of the genes have been cited as being induced by
flow or overexpression of KLF2 or KLF4 in different cell
types (mostly ECs; Table 1). Considering that the query genes
function in several other cellular pathways, selection of shear
stress-related genes up to 89 % further supported the robust-
ness of filtering procedure. Among the query genes, KLF2,
KLF4, and PKD2 were differentially expressed between
patients with BAVand TAV.
Gene expression profiles from mammary artery from the
same patient group (88 arrays) were used as controls as this
vessel is not under the direct influence of flow-mediated
effects by the valve. Similar to the ascending aorta, the
majority of genes from step 1 correlated with one or more
of the five query genes (76 of 122, data not shown), but no
gene that correlated with query genes showed differential
expression between patients with BAVand TAVat FDR 5 %
(Supplementary Table 2b).
Protein expression of GPR116, the most significantly
altered gene at mRNA level between BAVand TAV patients
(P01.99e−08), was analysed by immunohistochemistry in
non-dilated ascending aorta of BAV and TAV patients. As
seen in Fig. 2, a strong GPR116 expression was detected in
ECs of both BAV and TAV patients. In BAV patients, there
was also a strong staining in medial VSMCs, as opposed to
medial VSMCs from patients with TAV, in which the stain-
ing was much weaker. A similar expression pattern was
observed for the query gene PKD2 (Fig. 2).
Expression of flow-associated genes in regions
with different flow patterns in rat aorta
Genes identified as differentially expressed between BAV
and TAV patients (44 genes after filtering steps 1–3, Fig. 1)
were analysed in two regions exposed to different flow
patterns in the rat aortic arch; the distal part of the inner
curvature of the arch, subjected to a disturbed flow pattern
(i.e. a non-uniform WSS vector direction near the wall), and
a region along the outer curvature of the arch, directly after
the left subclavian artery, exposed to uniform flow fields
(i.e. a uniform WSS vector direction near the wall; Step 4,
Fig. 1). The regions have been identified in our lab
previously (Björck et al. manuscript), and RNA had
been extracted and subjected to global gene expression
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Table 1 Genes differentially expressed between flow regions in rat and between BAV and TAV
Gene RAT ASAP Flow Function(s) and properties
Disturbed vs uniform flow BAV vs TAV
P value Fold change P value Fold change
ZFP36L1 7.80E−07 −1.24b 0.0101 −1.64 X*4 Zinc finger protein, modulation and destabilization
VEGF mRNA, wound healing
ZFP36 1.08Ev−05 −1.37b 2.22E−05 −1.25 X*4 Modulation and destabilization VEGF mRNA,
wound healing
FLI1 6.60E−05 1.21 3.66E−06 −1.39 X Angiogenesis, maturation and stabilization of vessels,
wound healing
EGR1 7.98E−05 −1.42b 0.000777 −1.31 X Regulates angiopoietin-1 induced EC migration and
proliferation, wound healing
IER2 0.00012 −1.19b 0.000429 −1.17 X*4 Mediates EGF-dependent left–right asymmetry
patterning in zebrafish
SLC2A3 0.00019 1.36 6.51E−08 −1.44 X*4 Involved in tumour angiogenesis
FOSB 0.00031 −1.51b 1.23E−05 −1.42 X Induced by mechanical stress and cardiac ischemia and
VEGF, wound healing
TIMP1 0.00045 1.19 0.00329 −1.17 X Anti-angiogenesis, wound healing
GRK5 0.00053 1.19b 8.30E−05 1.17 X Regulation of vasoconstriction in VSMC, histone
deacetylase (HDAC) kinase in cardiomyocytes
CCL2 0.00093 −1.47b 1.32E−06 −1.80 X Involved in neovascularization and angiogenesis,
wound healing
NID1 0.00098 −1.14b 0.00197 −1.40 X Ingredient of vascular basement membranes,
wound healing
ITGA5 0.00115 −1.19b 9.00E−04 −1.74 X Fibronectin receptor
SOCS3 0.00119 −1.26b 2.84E−07 −1.35 X Negative regulator of cytokines, wound healing
FOS 0.00139 −1.34b 6.31E−05 −1.65 X Regulation of VEGF, angiogenesis, wound healing
KLF2 a 0.00207 −1.29b 0.0105 −1.10 X Regulates VEGFA, angiogenesis
BTG2 0.00314 −1.15b 1.35E−05 −1.30 X Anti-proliferative transcription factor involved in
modulation of VEGF-regulated wound repair
SGK1 0.01066 1.10 0.000461 −1.33 X Involved in vascular remodelling during angiogenesis,
wound healing
PLEKHO2 0.01227 1.10 6.75E−08 −1.25 ? No functional studies performed according to PubMed
PTGER4 0.01418 −1.29b 1.92E−06 −1.33 X Mediates prostaglandin E2 stimulated VEGF
expression, angiogenesis, wound healing
COL6A3 0.01504 1.10 9.00E−05 −1.24 X ECM component, regulated by TGF-β
FERMT2 0.02228 1.10b 0.000179 1.17 ? Wound healing, regulated by TGF-β1, angiogenesis
IL1R1 0.03103 0.0104 −1.21 X Wound healing
PKD2 a 0.04592 7.03E−07 1.30 X Ca2+-permeable channel of cilia, involved in embryonic
left right (LR) symmetry, wound healing
GEM 0.13107 0.000193 1.20 X Regulation of voltage-gated Ca2+ channel
DAB2 0.13354 0.000298 −1.30 X*2 Embryonic angiogenesis via VEGF induction,
TGF-β-stimulated fibronectin synthesis in wound
healing
GPR116 0.18922 1.99E−08 −1.86 X*2 Component of microvasculature
DUSP5 0.27924 8.17E−05 −1.16 X Strongly induced by VEGF in EC, EC specific in
vessels development
CEBPB 0.40525 0.000551 −1.12 ? Interacts directly with subunits of NF-kB to augment
gene expression by FOS transcription factors
KLF4a 0.44656 8.29E−05 −1.25 X Modulates phenotype of VSMCs, angiogenesis, wound
healing
SH2B3 0.48533 8.03E−07 −1.18 ? Stabilization of thrombi within vessels, regulates
EPC kinetics in vascular regeneration
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analysis. The array platform included 38 of the 44
identified genes. The mRNA expression of 21 genes
(55 %) differed (FDR 5 %, P<0.031) between uniform
and disturbed flow pattern regions (Table 1). Of these
genes, 15 (71 %) were either up- or downregulated in
the same direction in BAV and disturbed flow regions
(Table 1).
As shown in Fig. 3, PKD2 had higher mRNA expression
in regions exposed to a disturbed flow pattern when ana-
lysed with real-time PCR (real-time-PCR P00.011, gene
arrays P00.0459). Similarly, protein expression of PKD2
was increased in the vessel walls of rat aorta exposed to a
disturbed flow pattern compared with areas of uniform flow
(Supplementary Fig. 1). Furthermore, we also analysed the
expression of TNF and VCAM1, two known disturbed shear
stress-induced genes, as controls. Both TNF and VCAM1
were higher in the disturbed flow pattern regions than in the
uniform flow pattern regions (P00.0001 and P00.002, re-
spectively, Björck et al. manuscript).
The mRNA expression of the GPR116 showed a trend
towards increased mRNA expression in disturbed flow pat-
tern regions (P00.19). However, there was a significant
increase in mRNA expression in regions with a disturbed
flow pattern when analysed with real-time PCR (Fig. 3,
P00.045).
Downregulation of ZFP36 and ZFP36L1 expression
in regions of disturbed flow in rat and in aorta of BAV
patients
Among the 44 genes significantly altered in the ascending
aorta between BAVand TAV patients, the genes showing the
largest difference in expression between the two flow pat-
tern regions in rat were ZFP36 and ZFP36L1. ZFP36 and
Table 1 (continued)
Gene RAT ASAP Flow Function(s) and properties
Disturbed vs uniform flow BAV vs TAV
P value Fold change P value Fold change
JUNB 0.49141 2.60E−05 −1.40 X Regulates VEGF expression in an NF-kB-dependent
manner, angiogenesis, wound healing
CDH5 0.53465 2.52E−05 −1.23 X Ingredient of shear stress sensor complex, angiogenesis,
EC specific in vessel development
CD93 0.68071 0.000794 −1.22 X*2 Vascular remodelling and angiogenesis
CDKN1A 0.71809 0.002 −1.16 X Involved in regulation of EC senescence and
permeability, wound healing
PTPRE 0.79921 4.96E−07 −1.22 X Negative regulation of EC proliferation, possible role in
angiogenesis
CALD1 0.93732 0.00108 1.17 X*2 Anti-angiogenesis, cytoskeletal protein, implicated in
the migration of EPC
ERG 0.96645 0.00718 1.14 X*2 Angiogenesis, wound healing through regulation of
ECM
ELTD1 0.99016 3.03E−05 −1.52 X*4 Specifically expressed in the microvasculature
ENG NA NA 0.000117 −1.42 X Vascular TGF-β co-receptor, angiogenesis, wound
healing
PECAM1 NA NA 0.000899 −1.48 X Ingredient of shear stress sensor complex, angiogenesis,
wound healing
CEBPD NA NA 0.000296 −1.20 X*4 Interacts with subunits of NF-kB to augment gene
expression by FOS transcription factors
THBS1 NA NA 0.00201 −1.37 X Anti-angiogenesis, wound healing
KIAA0247 NA NA 5.25E−05 −1.17 ? Regulator of cell cycle
IL4R NA NA 1.23E−06 −1.34 X IL-4 receptor, IL-4 has been indicated in both
promoting and blocking angiogenesis
P values for differential expression between disturbed and uniform flow regions in rat aorta and for genes differentially expressed between BAVand
TAV are presented
X induced by shear stress according to the literature, X*2 by KLF2 or X*4 by KLF4 overexpression (extracted from literature search), ? not cited in
the literature, NA not analysed
a Query genes
b Fold changes for genes moving in the same direction in BAV and the areas of rat aorta exposed to disturbed flow
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ZFP36L1 are two closely related RNA-binding zinc finger
proteins binding to the 3′-untranslated regions of several
mRNAs and promote their degradation [19–21]. Both genes
showed significantly lower expression in regions with a
disturbed flow pattern and a significantly lower expression
in BAV compared with TAV patients. The differential ex-
pression of ZFP36 in rat aortic arch was further confirmed
using real-time PCR (Fig. 3). ZFP36 has previously been
shown to inhibit TNF production by destabilization of its
mRNA [19]. As expected, we observed a significant inverse
correlation between TNF and ZFP36 expression in rat
(P00.036, R200.19; Fig. 3). In addition, ZFP36 expression
was inversely correlated to VCAM1 expression (P00.030;
data not shown).
Protein expression of ZFP36 was analysed in ascending
aorta of BAV and TAV patients. As shown in Fig. 4, ECs in
TAV patients expressed ZFP36, whereas endothelial expres-
sion of ZFP36 was absent in BAV patients. In agreement
with real-time PCR and array expression data, ZFP36 stain-
ing was clearly decreased both in ECs and VSMCs in areas

















Fig. 2 Immunostaining of
GPR116 and PKD2 in non-
dilated aorta of BAV and TAV
patients. a, c GPR116 staining
in BAV; b, d GPR116 staining
in TAV; e, f vWF staining in
BAV and TAV, respectively; g
PKD2 staining in BAV;
h PKD2 staining in TAV; i, j
negative control. Scale
bar0100 μm
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Discussion
In this report, we analysed the ascending aortic gene expres-
sion profile in patients with BAV and TAV from a flow
perspective. Using a combination of methods, we described
a potential flow-mediated gene expression associated with
BAV and disclosed that a large proportion of the identified
genes were induced by shear stress and related to angiogen-
esis and/or wound healing. Importantly, in the same group
of patients, no genes were differentially expressed in the
mammary artery between BAV and TAV patients when the
same selection procedure was applied, suggesting that the
identified gene expression pattern was specific for the as-
cending aorta close to the aortic valve itself. It should be
emphasized that the differential expression of these genes is
most likely due to the aortic cusp morphology as athero-
sclerosis patients were excluded and other disease pheno-
types, i.e. dilatation, regurgitation and stenosis, were
included as covariates in the multivariate analysis. Using a
wider set of query genes further confirmed a robust co-
expression with queries. Moreover, 55 % of the identified
genes were differentially expressed between uniform and
disturbed flow in rat aorta.
Shear stress is sensed by ECs via a number of membrane-
associated mechanosensors, such as ion channels and
growth factor receptors, G protein-coupled receptors, adhe-
sion proteins, the cytoskeleton and primary cilia [6]. Genes
selected by our procedure belong to these groups (Table 1).
Most importantly, a differential expression of KLF2 and
KLF4, the two major flow-induced transcription factors,
and PECAM1 and CDH5, components of the mechanosen-
sory complex mediating EC responses to fluid shear stress
[22], was observed between BAV and TAV patients.
The gene function literature search, summarized in
Table 1, revealed that a large proportion of the genes differ-
entially expressed between BAVand TAV were either directly
or indirectly connected to angiogenesis. However, most pro-
angiogenesis genes (with the exception of ERG and FERMT2)
were downregulated, while genes with inhibitory effects on
angiogenesis (with the exception of THBS1) were upregulated
in BAV patients, indicating an angiostatic gene expression. As
expected, many genes involved in angiogenesis also regulated
wound healing processes in different types of tissues. One
likely explanation for the downregulation of angiogenesis/
wound healing genes in BAV patients may be a general
reduction of progenitor cells, as has been reported in BAV
patients with non-functional valves [23] and in patients with
aortic valve stenosis [24].
Endothelial progenitor cells (EPCs) originate either from
the vessel wall adjacent to the damaged vasculature or from
Fig. 3 Expression of query and
non-query genes in uniform and
disturbed flow pattern regions
of rat aorta. Shown are PKD2
(a), GPR116 (b) and ZFP36 (c)
mRNA expression. d Correla-
tion between ZFP36 and TNF
mRNA expression (n026).
Gene expression was analysed
by quantitative real-time PCR
and normalized to TBP mRNA
expression
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the bone marrow, and have been implicated in angiogenesis as
well as maintenance of EC integrity, adult neovascularization
and wound healing. The association of progenitor cells with
cardiovascular disease has been the subject of intensive inves-
tigations (for review see [25]), and enhanced proliferation of
EPC as a result of exposure to uniform shear stress [26, 27]
and overexpression of KLF2 [28] have been reported. It can
be hypothesized that exposure of the BAV aorta to abnormal
flow results in a decreased local angiogenesis due to reduced
number of EPCs, thereby contributing to a diminished repair
capacity and fragility of aorta. A similar mechanism has been
proposed for difficulties in wound healing in diabetic patients
[29]. This hypothesis fits well with our recently published
observation demonstrating a decreased expression of EDA
splice variant of fibronectin, which is important for tissue
repair, in VSMCs isolated from the BAVaorta compared with
VSMCs from the TAVaorta [30].
We showed for the first time that ZFP36 and ZFP36L1
were differentially expressed in the ascending aorta between
BAV and TAV patients, and that these genes were flow-
responsive in the rat aortic arch. ZFP36 was downregulated
in BAVaorta and in aortic regions exposed to disturbed flow
in rat, both at mRNA and protein level. In BAV patients, the
reduction was most prominent in the endothelial layer.
ZFP36 and ZFP36L1 regulate the stability of numerous
mRNAs, including TNF, VEGF and NFKB1 [19–21], and
possess anti-inflammatory properties. The downregulation
of ZFP36 in BAV may thus seem unexpected as we recently
reported an association of TAV morphology with an over-
expression of immune response-related genes [12]. The
function of this protein in aetiology of BAV is however
not known, but may be more associated with the regulation
of wound healing-related angiogenesis via regulation of
VEGF rather than inflammation (see below).
Abnormal expression of PKD2 in patients with polycys-
tic kidney disease has been associated with a range of
vascular abnormalities including BAV morphology [31],














Fig 4 Immunostaining of
ZFP36 in non-dilated aorta of
BAV (a, c) and TAV (b, d)
patients. e, f vWF staining in
BAV and TAV, respectively; g,
h negative control. Scale bar0
100 μm
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dissection of the thoracic aorta [16]. In VSMCs, PKD2
inhibits the activity of stretch-activated ion channels
(SACs), and elevated expression of PKD2 is associated with
impaired arterial myogenic tone via alteration of PKD1/
PKD2 ratio [32]. We observed a marked increase in PKD2
staining of VSMCs in BAVaorta compared with TAV, which
may well contribute to impaired VSMC function in BAV
aorta. However, EC exposure to disturbed flow may also
cause a difference in the expression of PKD2 in the VSMCs.
In mice, primary cilia have been shown to be more abundant
in regions exposed to low or oscillatory shear stress [33],
and ciliated ECs are restricted to areas exposed to disturbed
flow in the chick embryonic heart, in which the expression
of KLF2 is downregulated [8, 34]. Hence, increased number
of endothelial cilia in BAV patients, as a consequence of
disturbed flow, may be connected to upregulation of PKD2
in VSMCs. Whether or not disturbed shear stress can dif-
ferentially regulate SACs in VSMCs directly or indirectly
through EC signalling is unknown. Indeed, our results
showed that PKD2 and KLF2 expression were inversely
correlated. That was also true for the expression of majority
of the genes correlated to each one (Supplementary Table 1).
GPR116 and ELTD1 have previously been shown to be
EC-specific markers and broadly expressed in the vascular
endothelium [35]. Our data regarding the expression pattern
of GPR116 in association with BAV and perturbed flow are
not conclusive. The array results indicated that GPR116
expression was downregulated in the BAV aorta, while
immunostaining showed strong GPR116 expression in ECs
of both BAVand TAV patients. However, there was a strong
GPR116 staining in VSMCs of BAV patients. The discrep-
ancy between mRNA and protein expression is a common
phenomenon and may reflect changes in the regulation of
translation. Whether or not the absolute amount of GPR116
protein is increased in BAVor only in medial layer is hard to
establish by immunostaining, but the pattern of protein
distribution clearly differed between BAV and TAV.
Although our filtering successfully identified novel flow-
mediated genes associated with valve morphology, there are
some disadvantages of the selection procedure. The ana-
lysed mRNA contains a disproportionate mixture of EC
and VSMC messages, and co-expression analysis with que-
ry genes in the ASAP data set will not specify cell origin.
However, it is clear from our result that in spite of dispro-
portionate amount of EC and VSMC mRNA, our selection
procedure was capable of identifying several EC-specific
genes (i.e. PECAM1, CDH5 and several others, Table 1),
as well as detecting differential expression of ZFP36 protein
in ECs of the two patient groups, whereas in the case of
PKD2, the differential expression seems to be more due to
the VSMC. Due to the importance of media degeneration for
aneurysm development, we believe that this procedure is
more likely to capture real alterations in the vessel wall than
isolated EC or VSMC grown in culture media. This was
elegantly addressed in a study by Li et al. [17] in mice, in
which they showed that THBD was limited to the endothe-
lial layer in the normal vessel wall. However, when the
vessel was exposed to longer periods of high WSS, VSMCs
were activated and the vessel wall remodelled. The medial
change was accompanied by appearance of THBD in the
medial layer, and as discussed by the authors, this type of
vessel changes would not be captured by cell cultures.
In summary, the present study investigated flow-associated
gene expression in the ascending aorta of BAV and TAV
patients, using for the first time ‘expression screening’ in
human material. Taking advantage of a multi-step analysis
strategy, several novel genes associated with valve morphol-
ogy, particularly related to angiogenesis and wound healing,
were identified. Importantly, the majority of these genes were
subsequently validated as being flow-responsible in the rat
aortic arch. Moreover, our results extended our previous find-
ings on fibronectin splicing in VSMCs of BAV patients, and
its implication for VSMC repair, to vascular endothelial repair
deficiency, most probably laying the foundation for endothe-
lial dysfunction in BAV patients. However, although this work
identified several genes that appear to be modulated by BAV-
related changes in flow, their involvement in BAV-associated
aortopathy remains to be shown.
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